Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease.
- Published In:
- Bulletin of the Chemical Society of Japan, 97(5), uoae018 (2024)
- Authors:
- Miura, Takashi, Malla, Tika R, Brewitz, Lennart, Tumber, Anthony, Salah, Eidarus, Lee, Kang Ju, Terasaka, Naohiro, Owen, C David, Strain-Damerell, Claire, Lukacik, Petra, Walsh, Martin A, Kawamura, Akane, Schofield, Christopher J, Katoh, Takayuki, Suga, Hiroaki
- Database ID:
- RPEP-08881
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-08881APA
Miura, Takashi; Malla, Tika R; Brewitz, Lennart; Tumber, Anthony; Salah, Eidarus; Lee, Kang Ju; Terasaka, Naohiro; Owen, C David; Strain-Damerell, Claire; Lukacik, Petra; Walsh, Martin A; Kawamura, Akane; Schofield, Christopher J; Katoh, Takayuki; Suga, Hiroaki. (2024). Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease.. Bulletin of the Chemical Society of Japan, 97(5), uoae018. https://doi.org/10.1093/bulcsj/uoae018
MLA
Miura, Takashi, et al. "Cyclic β2,3-amino acids improve the serum stability of macrocyclic peptide inhibitors targeting the SARS-CoV-2 main protease.." Bulletin of the Chemical Society of Japan, 2024. https://doi.org/10.1093/bulcsj/uoae018
RethinkPeptides
RethinkPeptides Research Database. "Cyclic β2,3-amino acids improve the serum stability of macro..." RPEP-08881. Retrieved from https://rethinkpeptides.com/research/miura-2024-cyclic-23amino-acids-improve
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.